Drug intelligence / Profile preview

MiroFlex

Development stage: Unknown
Lead developer: Reprise Biomedical
Administration: Topical

Overview

MiroFlex Biologic Surgical Matrix is a non-crosslinked acellular surgical mesh developed by Reprise Biomedical for soft tissue reinforcement and wound care. Derived from decellularized porcine liver tissue using a proprietary perfusion decellularization technology, the device provides an open collagen scaffold with preserved natural vascular pathways. This structure is designed to facilitate cellular integration and tissue remodeling at the site of application. MiroFlex is primarily indicated for use in plastic and reconstructive surgery, specifically for reinforcing soft tissues in open and laparoscopic repairs of hiatal, paraesophageal, parastomal, and ventral hernias. It is designed to be custom-shaped and can be quilted together for larger hernia repairs.

Brand names: MiroFlex
Other names: MiroFlex Biologic Surgical Matrix

Beyond the preview

Go deeper on MiroFlex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiroFlex.

Explore the full profile